{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:07:52Z","timestamp":1789567672028,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s42000-026-00772-5","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T17:15:27Z","timestamp":1774545327000},"page":"377-387","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radiofrequency ablation as an alternative treatment for hyperparathyroidism: a case study of a single parathyroid adenoma and review of the literature"],"prefix":"10.1007","volume":"25","author":[{"given":"Maria Chrysoula Tatarida","family":"Palla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aspasia","family":"Drosou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pyrros","family":"Gkousis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Drakopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Styliani","family":"Kalaitzidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Veniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrsini","family":"Gkeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"772_CR1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1359\/JBMR.050910","volume":"21","author":"RA Wermers","year":"2006","unstructured":"Wermers RA, Khosla S, Atkinson EJ et al (2006) Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993\u20132001: an update on the changing epidemiology of the disease. J Bone Miner Res 21:171\u2013177. https:\/\/doi.org\/10.1359\/JBMR.050910","journal-title":"J Bone Miner Res"},{"key":"772_CR2","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1210\/jc.2012-4022","volume":"98","author":"MW Yeh","year":"2013","unstructured":"Yeh MW, Ituarte PHG, Zhou HC et al (2013) Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab 98:1122\u20131129. https:\/\/doi.org\/10.1210\/jc.2012-4022","journal-title":"J Clin Endocrinol Metab"},{"key":"772_CR3","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1210\/jc.2014-1413","volume":"99","author":"JP Bilezikian","year":"2014","unstructured":"Bilezikian JP, Brandi ML, Eastell R et al (2014) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 99:3561\u20133569. https:\/\/doi.org\/10.1210\/jc.2014-1413","journal-title":"J Clin Endocrinol Metab"},{"key":"772_CR4","doi-asserted-by":"publisher","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group (2017) KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl (2011) 7:1\u201359.https:\/\/doi.org\/10.1016\/j.kisu.2017.04.001","DOI":"10.1016\/j.kisu.2017.04.001"},{"key":"772_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2215\/CJN.12941213","volume":"10","author":"F Tentori","year":"2015","unstructured":"Tentori F, Wang M, Bieber BA et al (2015) Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clin J Am Soc Nephrol 10:98\u2013109. https:\/\/doi.org\/10.2215\/CJN.12941213","journal-title":"Clin J Am Soc Nephrol"},{"key":"772_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.surg.2021.03.067","volume":"171","author":"W Sutton","year":"2022","unstructured":"Sutton W, Chen X, Patel P et al (2022) Prevalence and risk factors for tertiary hyperparathyroidism in kidney transplant recipients. Surgery 171:69\u201376. https:\/\/doi.org\/10.1016\/j.surg.2021.03.067","journal-title":"Surgery"},{"key":"772_CR7","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","volume":"151","author":"SM Wilhelm","year":"2016","unstructured":"Wilhelm SM, Wang TS, Ruan DT et al (2016b) The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg 151:959. https:\/\/doi.org\/10.1001\/jamasurg.2016.2310","journal-title":"JAMA Surg"},{"key":"772_CR8","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/sla.0000000000000207","volume":"259","author":"DF Schneider","year":"2014","unstructured":"Schneider DF, Mazeh H, Chen H, Sippel RS (2014) Predictors of recurrence in primary hyperparathyroidism. Ann Surg 259:563\u2013568. https:\/\/doi.org\/10.1097\/sla.0000000000000207","journal-title":"Ann Surg"},{"key":"772_CR9","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","volume":"151","author":"SM Wilhelm","year":"2016","unstructured":"Wilhelm SM, Wang TS, Ruan DT et al (2016a) The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg 151:959. https:\/\/doi.org\/10.1001\/jamasurg.2016.2310","journal-title":"JAMA Surg"},{"key":"772_CR10","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1590\/2175-8239-JBN-2021-S107","volume":"43","author":"FR Hernandes","year":"2021","unstructured":"Hernandes FR, Goldenstein P, Cust\u00f3dio MR (2021) Treatment of hyperparathyroidism (SHPT). J Bras Nefrol 43:645\u2013649. https:\/\/doi.org\/10.1590\/2175-8239-JBN-2021-S107","journal-title":"J Bras Nefrol"},{"key":"772_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2482-14-26","volume":"14","author":"Q He","year":"2014","unstructured":"He Q, Zhuang D, Zheng L et al (2014) Total parathyroidectomy with trace amounts of parathyroid tissue autotransplantation as the treatment of choice for secondary hyperparathyroidism: a single-center experience. BMC Surg 14:26. https:\/\/doi.org\/10.1186\/1471-2482-14-26","journal-title":"BMC Surg"},{"key":"772_CR12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ijsu.2017.06.029","volume":"44","author":"M-E Liu","year":"2017","unstructured":"Liu M-E, Qiu N-C, Zha S-L et al (2017) To assess the effects of parathyroidectomy (TPTX versus TPTX\u2009+\u2009AT) for secondary hyperparathyroidism in chronic renal failure: a systematic review and meta-analysis. Int J Surg 44:353\u2013362. https:\/\/doi.org\/10.1016\/j.ijsu.2017.06.029","journal-title":"Int J Surg"},{"key":"772_CR13","doi-asserted-by":"publisher","first-page":"952","DOI":"10.2215\/CJN.10390917","volume":"13","author":"WL Lau","year":"2018","unstructured":"Lau WL, Obi Y, Kalantar-Zadeh K (2018) Parathyroidectomy in the management of secondary hyperparathyroidism. Clin J Am Soc Nephrol 13:952\u2013961. https:\/\/doi.org\/10.2215\/CJN.10390917","journal-title":"Clin J Am Soc Nephrol"},{"key":"772_CR14","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2023.2223370","volume":"40","author":"W Yue","year":"2023","unstructured":"Yue W, Jiang T, Deng E et al (2023) US-guided percutaneous radiofrequency ablation of secondary hyperparathyroidism as a bridge to renal transplantation. Int J Hyperthermia 40:2223370. https:\/\/doi.org\/10.1080\/02656736.2023.2223370","journal-title":"Int J Hyperthermia"},{"key":"772_CR15","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.233104","volume":"314","author":"Y Liu","year":"2025","unstructured":"Liu Y, Peng C-Z, Chai H-H et al (2025) US-guided thermal ablation for secondary hyperparathyroidism: a prospective multicenter study. Radiology 314:e233104. https:\/\/doi.org\/10.1148\/radiol.233104","journal-title":"Radiology"},{"key":"772_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/dc.24595","volume":"49","author":"A Suzuki","year":"2021","unstructured":"Suzuki A, Hirokawa M, Kanematsu R et al (2021) Fine-needle aspiration of parathyroid adenomas: indications as a diagnostic approach. Diagn Cytopathol 49:70\u201376. https:\/\/doi.org\/10.1002\/dc.24595","journal-title":"Diagn Cytopathol"},{"key":"772_CR17","doi-asserted-by":"publisher","DOI":"10.1210\/jcemcr\/luaf108","volume":"3","author":"AJ Rusnak","year":"2025","unstructured":"Rusnak AJ, Ryan SA, Boeddinghaus R et al (2025) Intrathyroidal fifth parathyroid adenoma: a rare cause of primary hyperparathyroidism. JCEM Case Reports 3:luaf108. https:\/\/doi.org\/10.1210\/jcemcr\/luaf108","journal-title":"JCEM Case Reports"},{"key":"772_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.14366\/usg.22105","volume":"42","author":"B Lee","year":"2023","unstructured":"Lee B, Chung SR, Choi YJ et al (2023) Diagnosis of parathyroid incidentaloma detected on thyroid ultrasonography: the role of fine-needle aspiration cytology and washout parathyroid hormone measurements. Ultrasonography 42:129\u2013135. https:\/\/doi.org\/10.14366\/usg.22105","journal-title":"Ultrasonography"},{"key":"772_CR19","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1007\/s00270-016-1544-6","volume":"40","author":"IC Sormaz","year":"2017","unstructured":"Sormaz IC, Poyanl\u0131 A, A\u00e7ar S et al (2017) The results of ultrasonography-guided percutaneous radiofrequency ablation in hyperparathyroid patients in whom surgery is not feasible. Cardiovasc Intervent Radiol 40:596\u2013602. https:\/\/doi.org\/10.1007\/s00270-016-1544-6","journal-title":"Cardiovasc Intervent Radiol"},{"key":"772_CR20","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1080\/02656736.2018.1453552","volume":"34","author":"H Korkusuz","year":"2018","unstructured":"Korkusuz H, Wolf T, Gr\u00fcnwald F (2018) Feasibility of bipolar radiofrequency ablation in patients with parathyroid adenoma: a first evaluation. Int J Hyperth 34:639\u2013643. https:\/\/doi.org\/10.1080\/02656736.2018.1453552","journal-title":"Int J Hyperth"},{"key":"772_CR21","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3348\/kjr.2020.0037","volume":"21","author":"EJ Ha","year":"2020","unstructured":"Ha EJ, Baek JH, Baek SM (2020) Minimally invasive treatment for benign parathyroid lesions: treatment efficacy and safety based on nodule characteristics. Korean J Radiol 21:1383\u20131392. https:\/\/doi.org\/10.3348\/kjr.2020.0037","journal-title":"Korean J Radiol"},{"key":"772_CR22","doi-asserted-by":"publisher","first-page":"543","DOI":"10.4103\/ijem.IJEM_671_20","volume":"24","author":"AH Khandelwal","year":"2020","unstructured":"Khandelwal AH, Batra S, Jajodia S et al (2020) Radiofrequency ablation of parathyroid adenomas: safety and efficacy in a study of 10 patients. Indian J Endocrinol Metab 24:543\u2013550. https:\/\/doi.org\/10.4103\/ijem.IJEM_671_20","journal-title":"Indian J Endocrinol Metab"},{"key":"772_CR23","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.eprac.2021.07.012","volume":"27","author":"X Li","year":"2021","unstructured":"Li X, Tufano RP, Russell JO et al (2021) Ultrasound-guided radiofrequency ablation for the treatment of primary hyperparathyroidism: an efficacy and safety study. Endocr Pract 27:1205\u20131211. https:\/\/doi.org\/10.1016\/j.eprac.2021.07.012","journal-title":"Endocr Pract"},{"key":"772_CR24","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/jcu.23181","volume":"50","author":"H Ebrahiminik","year":"2022","unstructured":"Ebrahiminik H, Chegeni H, Mosadegh Khah A et al (2022) Radiofrequency ablation of parathyroid adenomas causing primary hyperparathyroidism: a report of 27 patients. J Clin Ultrasound 50:540\u2013546. https:\/\/doi.org\/10.1002\/jcu.23181","journal-title":"J Clin Ultrasound"},{"key":"772_CR25","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1080\/02656736.2022.2047231","volume":"39","author":"C-Z Peng","year":"2022","unstructured":"Peng C-Z, Chai H-H, Zhang Z-X et al (2022) Radiofrequency ablation for primary hyperparathyroidism and risk factors for postablative eucalcemic parathyroid hormone elevation. Int J Hyperthermia 39:490\u2013496. https:\/\/doi.org\/10.1080\/02656736.2022.2047231","journal-title":"Int J Hyperthermia"},{"key":"772_CR26","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3348\/kjr.2021.0716","volume":"23","author":"H-H Chai","year":"2022","unstructured":"Chai H-H, Zhao Y, Zeng Z et al (2022) Efficacy and safety of ultrasound-guided radiofrequency ablation for primary hyperparathyroidism: a prospective study. Korean J Radiol 23:555\u2013565. https:\/\/doi.org\/10.3348\/kjr.2021.0716","journal-title":"Korean J Radiol"},{"key":"772_CR27","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1080\/02656736.2022.2097324","volume":"39","author":"C-C Chen","year":"2022","unstructured":"Chen C-C, Chen H-L, Chiang P-L et al (2022) Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism with or without previous parathyroidectomy: a retrospective study. Int J Hyperthermia 39:907\u2013917. https:\/\/doi.org\/10.1080\/02656736.2022.2097324","journal-title":"Int J Hyperthermia"},{"key":"772_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-44204-5","volume":"13","author":"X Qiu","year":"2023","unstructured":"Qiu X, Gao M, Zhang D, Ji F (2023) Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism: a retrospective study. Sci Rep 13:16949. https:\/\/doi.org\/10.1038\/s41598-023-44204-5","journal-title":"Sci Rep"},{"key":"772_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.21037\/gs-22-546","volume":"13","author":"PP Issa","year":"2024","unstructured":"Issa PP, Kandil E, Lee GS (2024) Radiofrequency ablation as a treatment modality for primary hyperparathyroidism: a systematic literature review. Gland Surg 13:87\u201399. https:\/\/doi.org\/10.21037\/gs-22-546","journal-title":"Gland Surg"},{"key":"772_CR30","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1007\/s40618-023-02078-4","volume":"46","author":"S Le\u00f3n Utrero","year":"2023","unstructured":"Le\u00f3n Utrero S, Garrido-Pareja F, L\u00f3pez-Ibarra P et al (2023) Effectiveness and safety of the radiofrequency ablation of single hyperfunctioning parathyroid lesions suggestive of adenomas in primary hyperparathyroidism. J Endocrinol Invest 46:2269\u20132273. https:\/\/doi.org\/10.1007\/s40618-023-02078-4","journal-title":"J Endocrinol Invest"},{"key":"772_CR31","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1007\/s00270-024-03725-w","volume":"47","author":"H Chehrehgosha","year":"2024","unstructured":"Chehrehgosha H, Chegini H, Heydari I et al (2024) Radiofrequency ablation of parathyroid adenoma: results of a retrospective analysis of 60 patients. Cardiovasc Intervent Radiol 47:762\u2013770. https:\/\/doi.org\/10.1007\/s00270-024-03725-w","journal-title":"Cardiovasc Intervent Radiol"},{"key":"772_CR32","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s00330-025-11860-2","volume":"36","author":"EJ Ha","year":"2026","unstructured":"Ha EJ, Kim J-H, Lee JY et al (2026) Radiofrequency ablation for patients with primary hyperparathyroidism: a multicenter non-randomized open-label single-arm prospective clinical trial. Eur Radiol 36:396\u2013405. https:\/\/doi.org\/10.1007\/s00330-025-11860-2","journal-title":"Eur Radiol"},{"key":"772_CR33","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/hed.28032","volume":"47","author":"ALS Rodrigues","year":"2025","unstructured":"Rodrigues ALS, de O, Pereira LC, Cabral TDD et al (2025) Efficacy of radiofrequency ablation-guided by ultrasound in primary hyperparathyroidism: A systematic review and meta-analysis. Head Neck 47:1504\u20131511. https:\/\/doi.org\/10.1002\/hed.28032","journal-title":"Head Neck"},{"key":"772_CR34","doi-asserted-by":"publisher","first-page":"6583","DOI":"10.1007\/s00330-025-11581-6","volume":"35","author":"SY Jeong","year":"2025","unstructured":"Jeong SY, Lee KH, Lee JY et al (2025) Efficacy and safety of radiofrequency ablation for hyperparathyroidism: a meta-analysis and systematic review. Eur Radiol 35:6583\u20136597. https:\/\/doi.org\/10.1007\/s00330-025-11581-6","journal-title":"Eur Radiol"},{"key":"772_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-63299-8","volume":"10","author":"Z Zeng","year":"2020","unstructured":"Zeng Z, Peng C-Z, Liu J-B et al (2020) Efficacy of ultrasound-guided radiofrequency ablation of parathyroid hyperplasia: single session vs. two-session for effect on hypocalcemia. Sci Rep 10:6206. https:\/\/doi.org\/10.1038\/s41598-020-63299-8","journal-title":"Sci Rep"},{"key":"772_CR36","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ekir.2021.11.038","volume":"7","author":"D-L Zhang","year":"2022","unstructured":"Zhang D-L, Chen S, Gao M-Z et al (2022) Ultrasound-guided radiofrequency ablation: a new attempt to the treatment of refractory hyperparathyroidism secondary to chronic kidney disease. Kidney Int Rep 7:282\u2013288. https:\/\/doi.org\/10.1016\/j.ekir.2021.11.038","journal-title":"Kidney Int Rep"},{"key":"772_CR37","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/0886022X.2021.1889601","volume":"43","author":"X Qin","year":"2021","unstructured":"Qin X, Wang B, Li B et al (2021) Value of contrast-enhanced ultrasonography in radiofrequency ablation of secondary hyperparathyroidism. Ren Fail 43:445\u2013451. https:\/\/doi.org\/10.1080\/0886022X.2021.1889601","journal-title":"Ren Fail"},{"key":"772_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-14623-x","volume":"12","author":"M Ren","year":"2022","unstructured":"Ren M, Zheng D, Wu J et al (2022) Efficacy and safety of radiofrequency ablation versus parathyroidectomy for secondary hyperparathyroidism in dialysis patients: a single-center retrospective study. Sci Rep 12:10289. https:\/\/doi.org\/10.1038\/s41598-022-14623-x","journal-title":"Sci Rep"},{"key":"772_CR39","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s12020-023-03513-5","volume":"83","author":"T Jiang","year":"2024","unstructured":"Jiang T, Deng E, Chai H et al (2024) Radiofrequency ablation for patients with recurrent or persistent secondary hyperparathyroidism after parathyroidectomy: initial experience. Endocrine 83:681\u2013690. https:\/\/doi.org\/10.1007\/s12020-023-03513-5","journal-title":"Endocrine"},{"key":"772_CR40","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3348\/kjr.2023.0176","volume":"25","author":"E Deng","year":"2024","unstructured":"Deng E, Jiang T, Chai H et al (2024) Ultrasound-guided radiofrequency ablation in tertiary hyperparathyroidism: a prospective study. Korean J Radiol 25:289\u2013300. https:\/\/doi.org\/10.3348\/kjr.2023.0176","journal-title":"Korean J Radiol"},{"key":"772_CR41","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2478\/abm-2024-0036","volume":"18","author":"M Li","year":"2024","unstructured":"Li M, Jiang H, Wang Y, Li F (2024) Efficacy and safety of radiofrequency ablation for secondary hyperparathyroidism: a systematic review and meta-analysis. Asian Biomed (Res Rev News) 18:287\u2013296. https:\/\/doi.org\/10.2478\/abm-2024-0036","journal-title":"Asian Biomed (Res Rev News)"},{"key":"772_CR42","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/hed.24657","volume":"39","author":"C Peng","year":"2017","unstructured":"Peng C, Zhang Z, Liu J et al (2017) Efficacy and safety of ultrasound-guided radiofrequency ablation of hyperplastic parathyroid gland for secondary hyperparathyroidism associated with chronic kidney disease. Head Neck 39:564\u2013571. https:\/\/doi.org\/10.1002\/hed.24657","journal-title":"Head Neck"},{"key":"772_CR43","doi-asserted-by":"publisher","first-page":"142","DOI":"10.13201\/j.issn.1001-1781.2018.02.016","volume":"32","author":"SJ Bo","year":"2018","unstructured":"Bo SJ, Xu XF, Qiu CY et al (2018) Re-operation treatment in uremic patients complicated with persistent secondary hyperparathyroidism after parathyroidectomy with autotransplantation. Lin Chuang Er Bi Yan Hou Tou Jing Wai. Ke Za Zhi 32:142\u2013147. https:\/\/doi.org\/10.13201\/j.issn.1001-1781.2018.02.016","journal-title":"Ke Za Zhi"},{"key":"772_CR44","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1210\/clinem\/dgab240","volume":"106","author":"Y Wei","year":"2021","unstructured":"Wei Y, Peng C-Z, Wang S-R et al (2021) Effectiveness and safety of thermal ablation in the treatment of primary hyperparathyroidism: a multicenter study. J Clin Endocrinol Metab 106:2707\u20132717. https:\/\/doi.org\/10.1210\/clinem\/dgab240","journal-title":"J Clin Endocrinol Metab"},{"key":"772_CR45","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1007\/s11255-023-03543-y","volume":"55","author":"W Xu","year":"2023","unstructured":"Xu W, Li S, Cheng F et al (2023) Microwave ablation versus radiofrequency ablation for patients with primary and secondary hyperparathyroidism: a meta-analysis. Int Urol Nephrol 55:2237\u20132247. https:\/\/doi.org\/10.1007\/s11255-023-03543-y","journal-title":"Int Urol Nephrol"},{"key":"772_CR46","doi-asserted-by":"publisher","first-page":"e3150","DOI":"10.1210\/clinem\/dgaf270","volume":"110","author":"C Bilgin","year":"2025","unstructured":"Bilgin C, Hibbert R, Oztepe F et al (2025) Percutaneous ablation of parathyroid adenomas: a systematic review and meta-analysis. J Clin Endocrinol Metab 110:e3150\u2013e3162. https:\/\/doi.org\/10.1210\/clinem\/dgaf270","journal-title":"J Clin Endocrinol Metab"},{"key":"772_CR47","doi-asserted-by":"publisher","first-page":"6696","DOI":"10.1007\/s00330-025-11688-w","volume":"35","author":"T Jiang","year":"2025","unstructured":"Jiang T, Chai H, Shan X et al (2025) Safety of radiofrequency ablation in patients with hyperparathyroidism: a 10-year real-world multicenter experience. Eur Radiol 35:6696\u20136707. https:\/\/doi.org\/10.1007\/s00330-025-11688-w","journal-title":"Eur Radiol"},{"key":"772_CR48","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2023.2215334","volume":"45","author":"L-P Lin","year":"2023","unstructured":"Lin L-P, Lin M, Wu S-S et al (2023) Complications after radiofrequency ablation of hyperparathyroidism secondary to chronic kidney disease. Ren Fail 45:2215334. https:\/\/doi.org\/10.1080\/0886022X.2023.2215334","journal-title":"Ren Fail"},{"key":"772_CR49","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.21037\/gs-23-289","volume":"12","author":"C McManus","year":"2023","unstructured":"McManus C (2023) Radiofrequency ablation for primary hyperparathyroidism: are we there yet? Gland Surg 12:1028\u20131030. https:\/\/doi.org\/10.21037\/gs-23-289","journal-title":"Gland Surg"},{"issue":"3","key":"772_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013035.pub2","volume":"2023","author":"JM Pappachan","year":"2023","unstructured":"Pappachan JM, Lahart IM, Viswanath AK et al (2023) Parathyroidectomy for adults with primary hyperparathyroidism. Cochrane Database Syst Rev (3):CD013035. https:\/\/doi.org\/10.1002\/14651858.CD013035.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"772_CR51","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/s12020-020-02275-8","volume":"69","author":"P Trimboli","year":"2020","unstructured":"Trimboli P, Deandrea M (2020) Treating thyroid nodules by radiofrequency: is the delivered energy correlated with the volume reduction rate? A pilot study. Endocrine 69:682\u2013687. https:\/\/doi.org\/10.1007\/s12020-020-02275-8","journal-title":"Endocrine"},{"key":"772_CR52","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.surg.2005.06.046","volume":"138","author":"H Chen","year":"2005","unstructured":"Chen H, Pruhs Z, Starling JR, Mack E (2005) Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery 138:583\u20137. https:\/\/doi.org\/10.1016\/j.surg.2005.06.046","journal-title":"Surgery"},{"key":"772_CR53","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.bjps.2008.03.020","volume":"61","author":"BC Brown","year":"2008","unstructured":"Brown BC, McKenna SP, Siddhi K et al (2008) The hidden cost of skin scars: quality of life after skin scarring. J Plast Reconstr Aesthet Surg 61:1049\u20131058. https:\/\/doi.org\/10.1016\/j.bjps.2008.03.020","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"772_CR54","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00405-017-4836-9","volume":"275","author":"R de la Plaza Llamas","year":"2018","unstructured":"de la Plaza Llamas R, Ramia \u00c1ngel JM, Arteaga Peralta V et al (2018) Elevated parathyroid hormone levels after successful parathyroidectomy for primary hyperparathyroidism: a clinical review. Eur Arch Otorhinolaryngol 275:659\u2013669. https:\/\/doi.org\/10.1007\/s00405-017-4836-9","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"772_CR55","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.coph.2015.03.005","volume":"22","author":"BC Silva","year":"2015","unstructured":"Silva BC, Bilezikian JP (2015) Parathyroid hormone: anabolic and catabolic actions on the skeleton. Curr Opin Pharmacol 22:41\u201350. https:\/\/doi.org\/10.1016\/j.coph.2015.03.005","journal-title":"Curr Opin Pharmacol"},{"key":"772_CR56","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1067\/msy.1998.92004","volume":"124","author":"AK Mandal","year":"1998","unstructured":"Mandal AK, Udelsman R (1998) Secondary hyperparathyroidism is an expected consequence of parathyroidectomy for primary hyperparathyroidism: a prospective study. Surgery 124:1021\u20131027. https:\/\/doi.org\/10.1067\/msy.1998.92004","journal-title":"Surgery"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-026-00772-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-026-00772-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-026-00772-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:31:59Z","timestamp":1789565519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-026-00772-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["772"],"URL":"https:\/\/doi.org\/10.1007\/s42000-026-00772-5","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"10 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests, whether financial or non-financial, related to the content of this manuscript.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}